Overview
- Bristol Myers Squibb announced the investment on Monday, Aug. 10, 2026, selecting Generation Park in northeast Houston for a roughly 600,000-square-foot modular campus.
- The company said the site will be multimodal, able to make small-molecule drugs, biologics and antibody-drug conjugates so it can reconfigure capacity as pipeline needs change.
- BMS expects nearly 500 permanent skilled jobs at the campus and about 2,000 construction and related jobs during the 2027–2030 buildout period.
- Texas offered a $4.89 million Texas Enterprise Fund grant and the project qualifies for state JETI incentives, with officials citing local workforce, infrastructure and a pro-growth business climate as decision factors.
- The Houston move is part of a broader industry shift to expand U.S. manufacturing capacity as drugmakers respond to recent federal trade measures and corporate plans to reshore production.